Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viking Thera (NQ: VKTX )

53.26 +1.63 (+3.16%)
Streaming Delayed Price Updated: 1:24 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viking Thera

< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
5 Most Expensive Health Care Stocks You Should Worry About
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
This Stock That Tripled in 2022 Could Rocket Even Higher in 2023
Potential suitors with heaps of cash to spend are lining up to get a closer look at this company's results. 
Via The Motley Fool
Here's How Much $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
Via Benzinga
Why Did Viking Therapeutics Stock Skyrocket
VKTX stock is young but strong and they have excellent potential, particularly following successful trial results from Madrigal Pharma's recent drug trial. 
Via MarketBeat
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Recap: Viking Therapeutics Q3 Earnings
Viking Therapeutics (NASDAQ:VKTX) reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Recap: Viking Therapeutics Q2 Earnings
Viking Therapeutics (NASDAQ:VKTX) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
FDA Lifts Clinical Hold On Viking Therapeutics' Rare Metabolic Disorder Study
Via Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. 
Via Benzinga
Is Elon Musk Stepping Down as Head of Twitter?
Elon Musk is in the news Monday after the billionaire held a poll asking if he should step down as head of social media company Twitter. 
Via InvestorPlace
Madrigal Pharmaceuticals, Cerevel Therapeutics And Some Other Big Stocks Moving Higher On Monday
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 90 points on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why Is Cosmos Health (COSM) Stock Down 58% Today?
Cosmos Health (COSM) stock is falling hard on Monday after the healthcare company's shares underwent a major rally on Friday! 
Via InvestorPlace
Tesla's Bouncing, but This Nasdaq Stock Tripled Monday Morning
Good news can come in different forms. 
Via The Motley Fool
Why Is Viking Therapeutics (VKTX) Stock Up 67% Today?
Viking Therapeutics (VKTX) stock is taking off on Monday with heavy trading without any news from the biopharmaceutical company. 
Via InvestorPlace
US Stocks Slightly Lower; Nasdaq Down 100 Points
U.S. stocks traded slightly lower this morning, with the Nasdaq Composite dropping around 100 points on Monday. 
Via Benzinga
Why Viking Therapeutics Stock Is Moving Alongside Madrigal Pharmaceuticals Shares Today
Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Monday, in sympathy with Madrigal Pharmaceuticals Inc (NASDAQ: MDGL), which announced a suc 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
My 3 Top Biotech Stock Picks for 2023
Biotech stocks are set to shine in 2023. 
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Earnings Outlook For Viking Therapeutics
Viking Therapeutics (NASDAQ:VKTX) is set to give its latest quarterly earnings report on Wednesday, 2022-10-26. Here's what investors need to know before the announcement. Analysts estimate that Viking... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
Earnings Scheduled For October 26, 2022
Companies Reporting Before The Bell • LG Display Co (NYSE:LPL) is projected to report quarterly loss at $0.41 per share on revenue of $4.90 billion. 
Via Benzinga
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Earnings Scheduled For July 27, 2022
Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report earnings for its second quarter. 
Via Benzinga
Viking Therapeutics Earnings Preview
Viking Therapeutics (NASDAQ:VKTX) is set to give its latest quarterly earnings report on Wednesday, 2022-07-27. Here's what investors need to know before the announcement. Analysts estimate that Viking... 
Via Benzinga
Recap of Tuesday's Biotech Catalysts - End Of The Day Summary
The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness... 
Via Benzinga
U.S. FDA Lifts Clinical Hold On Viking Therapeutics' Initial-Stage Genetic Disorder Study
Viking Therapeutics (NASDAQ: VKTX) announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold placed on the clinical trial of VK0214 in patients with X-linked... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 7.7% to $2.66 during Friday's after-market session. The market value of their outstanding shares is at $144.4 million. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
During Monday's trading, 1214 companies set new 52-week lows. 
Via Benzinga
< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.